Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-B1521 |
Brand: | MCE |
CAS: | 21645-51-2 |
MDL | MFCD00003420 |
---|---|
Molecular Weight | 78.00 |
Molecular Formula | AlH3O3 |
SMILES | O[Al](O)O |
Aluminum Hydroxide is an orally active main form of aluminum used as adjuvant. Aluminum hydroxide-based adjuvant researches include the repository effect, pro-phagocytic effect, and activation of the pro-inflammatory NLRP3 pathway. Aluminum Hydroxide also acts as adjuvant to compensate low inherent immunogenicity of subunit vaccines [1] [2] .
Aluminum Hydroxide (orally; 100 mg/kg/day for 7 days) increases lipid peroxidation and decreases the activity of SOD in the brain. Aluminum Hydroxide can dissolve in distilled water to be a homogeneous suspension [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT00031109 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections
|
Not Applicable | |
NCT01837446 | Isfahan University of Medical Sciences |
Stomatitis
|
July 2011 | Phase 2|Phase 3 |
NCT00000809 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections|HIV Seronegativity
|
Phase 1 | |
NCT01376765 | National Institute of Allergy and Infectious Diseases (NIAID) |
SARS
|
Phase 1 | |
NCT04915768 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections
|
May 3, 2021 | Phase 1 |
NCT03755427 | Shanghai Institute Of Biological Products |
H7N9 Influenza
|
November 2018 | Phase 2 |
NCT00854776 | Taipei Veterans General Hospital, Taiwan |
Peptic Ulcer|Ulcer Complications
|
January 2009 | Not Applicable |
NCT02298179 | GlaxoSmithKline |
Respiratory Syncytial Virus (RSV)
|
December 19, 2014 | Phase 1 |
NCT00001906 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) |
Cutaneous Leishmaniasis
|
April 1999 | Phase 1 |
NCT03589768 | National Institute of Allergy and Infectious Diseases (NIAID) |
Clostridium Difficile Immunisation|Diphtheria|Diphtheria Immunisation|Pertussis|Tetanus|Tetanus Immunisation
|
January 24, 2019 | Phase 2 |
NCT00280033 | National Institute of Allergy and Infectious Diseases (NIAID) |
Influenza
|
February 2006 | Phase 1|Phase 2 |
NCT00974935 | National Institute of Allergy and Infectious Diseases (NIAID) |
Toxic Shock Syndrome Staphylococcal
|
February 2011 | Phase 1 |
NCT02116998 | Genocea Biosciences, Inc. |
Pneumococcal Infections|Pneumonia, Pneumococcal
|
September 2014 | Phase 2 |
NCT00263744 | MedImmune LLC|GlaxoSmithKline |
Healthy
|
November 1999 | Phase 1|Phase 2 |
NCT00000779 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections
|
Phase 1 | |
NCT05561673 | GlaxoSmithKline |
Hepatitis B
|
October 4, 2022 | Phase 1|Phase 2 |
NCT00001042 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections
|
Phase 1 | |
NCT00529399 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute of Allergy and Infectious Diseases (NIAID)|National Center for Research Resources (NCRR)|American Diabetes Association|Juvenile Diabetes Research Foundation |
Type 1 Diabetes Mellitus
|
February 2009 | Phase 2 |
NCT00001052 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections
|
Phase 1 | |
NCT03382418 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections
|
December 27, 2017 | Phase 1 |
NCT00296634 | National Institute of Allergy and Infectious Diseases (NIAID) |
Influenza
|
March 2006 | Phase 1|Phase 2 |
NCT00294099 | National Institute of Allergy and Infectious Diseases (NIAID) |
Influenza
|
March 2006 | Phase 1|Phase 2 |
NCT01280968 | Alexey Mukhin|Wake Forest University Health Sciences|Novartis Pharmaceuticals|Duke University |
Nicotine Dependence
|
December 2010 | Phase 2 |
NCT00002402 | VaxGen|NIH AIDS Clinical Trials Information Service |
HIV Infections
|
Phase 1 | |
NCT00000868 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections|HIV Seronegativity
|
Phase 1 | |
NCT02067676 | U.S. Army Medical Research and Development Command|Walter Reed Army Institute of Research (WRAIR) |
Campylobacter Infection
|
April 21, 2014 | Phase 1 |
NCT00001053 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections
|
Phase 1 | |
NCT03369808 | Shanghai Institute Of Biological Products|Henan Center for Disease Control and Prevention |
H7N9 Influenza
|
December 29, 2017 | Phase 1|Phase 2 |
NCT00018135 | National Center for Research Resources (NCRR) |
Renal Failure
|
Not Applicable | |
NCT03049488 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) |
Respiratory Syncytial Virus
|
February 22, 2017 | Phase 1 |
NCT00533741 | National Institute of Allergy and Infectious Diseases (NIAID) |
Coronavirus (SARS-CoV)
|
Phase 1 | |
NCT05131295 | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez |
Subarachnoid Hemorrhage|Brain Ischemia|Subarachnoid Hemorrhage, Aneurysmal|Aneurysmal Subarachnoid Hemorrhage|Delayed Cerebral Ischemia|Vasospasm, Cerebral
|
September 5, 2007 | Phase 3 |
NCT00001044 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections
|
Phase 1 | |
NCT00382980 | National Institute of Allergy and Infectious Diseases (NIAID) |
Influenza
|
October 2006 | Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)
Add each solvent one by one: 0.5% CMC-Na /saline water
Solubility: 10 mg/mL (128.21 mM); Suspended solution; Need ultrasonic
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.